Delivery Order SPE2DB24D2205-SPE2DB24FDTYL

Award Date 5/10/24
Potential Completion Date 6/3/24
Potential Value $9.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Cosentyx Unoready 300 mg pen. The contract has a ceiling value of $1,521.95 and a completion date of May 9, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The $3,043.90 firm fixed price contract is for the supply of Cosentyx Unoready 300 mg pen injectors. This delivery order is issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC enables the DLA to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of Cosentyx Unoready 300 mg pens. The contract has a firm fixed price of $16,648.24 and an ultimate completion date of July 24, 2024. AmerisourceBergen is a large pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical commodities, including specialty medications, vaccines, and medical supplies, to support various...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,087.80, is for the delivery of Cosentyx Unoready 300 mg pen, a specialty medication. The contract has a firm fixed price and has an ultimate completion date of May 23, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $6,087.80 firm fixed-price contract is for the supply of Cosentyx Unoready 300 mg pen 2 ml, a specialty medication. The contract has a completion date of September 5, 2024 and is not designated as a set-aside. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up...
The U.S. Defense Logistics Agency (DLA) awarded a $6,293.00 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to supply the pharmaceutical product Cosentyx SNRDY 300MG DOSE-2PENML. This order is part of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply the pharmaceutical product Cosentyx Unoready 300 mg pen in 2 ml. The $1,521.95 contract has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) awarded by DLA, valued at up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Cosentyx Unoready 300 mg pen, 2 ml to the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price of $9,131.70 and an ultimate completion date of July 24, 2024. The contract was awarded on July 2, 2024 and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The $9,131.70 firm fixed price delivery order is for the supply of Cosentyx Unoready 300 mg pen, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a...
This is a delivery order award to Amerisourcebergen Drug Corporation's Corporate Office division, a for-profit pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The award is for $19,044.37 to supply the drug Cosentyx Unoready 300 mg Pen 2 ml. The contract has a ceiling value of $19,044.37 and an ultimate completion date of August 28, 2024. This appears to be a firm fixed-price, delivery order contract that is not designated as a set-aside. Amerisourcebergen is a major...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDTYL
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Cosentyx Unoready 300 mg pen 2 ml. The $9,131.70 fixed-price order has a completion date of June 3, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 8/9/24, 9:04 AM